Market Research Logo

Global Veterinary Diagnostics Market Research Report Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Veterinary Diagnostics Market Research Report Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

"The global veterinary diagnostics market is expected to grow with the CAGR of approximately 9.4% during the forecast period (2016-2023). The factors that are positively affecting the market growth are increasing consumer spending on pets, increasing livestock population, increasing prevalence of animal diseases across the globe, increasing demand for animal-derived food products and innovation in veterinary diagnostics. Regarding laboratory based diagnosis, polymerase chain reaction (PCR) is being broadly used method to identify the nucleic acids in clinical sample as a highly rapid alternative to various detection methods, primarily for Avian Influenza A virus. Several versions of PCR such as nested PCR (for overall genome sequencing of pestiviruses) and Real-Time PCR) (for variation of morbilli virus regarding insertion sequence analysis for Mycobacterium paratuberculosis) as well as multiplex PCR (for distinguishing the cluster of various viruses, causing diseases in swine) has led to improve the ability of veterinary diagnosticians time to time. Fast innovations in molecular biology offer new powerful diagnostic techniques such as PCR (Polymerase Chain Reaction) etc. Nano-based and refined diagnostic methods are primarily receiving maximum attention due to the development in the sector of agricultural biotechnology. Particular Influenza virus strain detection and the use of gold nanoparticles are quiet important in this regard. The use of DNA biotechnology for animal health (for example, micro- array based diagnosis for species and type level variation of viruses who are belonging to the family Picornaviridae) also contribute to develop animal disease control program and can stimulate both livestock trade and food production . There are some crucial factors restraining the market growth such as increasing trend towards vegetarian diet and high cost associated with veterinary diagnostic tests. Increasing demand for pet insurance and increasing awareness regarding animal health in developing countries are creating good opportunity for the market. The market is facing certain challenge i.e. lack of veterinarians in developing countries. Geographically, North America was occupied major share in terms of revenue in 2015 due to increasing expenditure on pets. However, Asia Pacific is expected to be the fastest growing region due to increasing prevalence of animal diseases such as rabies along with increasing awareness regarding animal health in the region. The presence of major players such as Bio-Rad Laboratories, Inc. (U.S.), Pfizer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Idexx Laboratories, Inc. (U.S.), Qiagen NV (Germany), Zoetis, Inc. (U.S.), Acon Laboratories, Inc. (U.S.), Horiba, Ltd. (Japan) and Abbott Laboratories (U.S.) etc. are creating opportunity for more advancements in veterinary diagnostics which as a result will further enhance the accuracy and reliability of testing. The global veterinary diagnostics market is segmented on the basis of technology, product, animal type and application. The technology segment is further segmented into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, hematology analyzers and other technologies. The product segment is further classified into consumables and instruments. The animal type is further categorized into companion and farm animals. The application segment is classified into reference laboratories, veterinary hospitals and clinics, point-of-care/in-house testing, research institutions & universities. " Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL VETERINARY IMAGING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. GROWING ANIMAL HEALTH EXPENDITURE AND RISING DEMAND FOR PET INSURANCE
3.1.2. INNOVATIONS IN VETERINARY IMAGING INSTRUMENTS
3.1.3. GROWTH IN THE NUMBER OF VETERINARY PRACTITIONERS & RISE IN THEIR INCOME LEVELS IN DEVELOPED ECONOMIES
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF VETERINARY IMAGING INSTRUMENTS
3.2.2. INCREASING PET CARE COSTS
3.3. MARKET OPPORTUNITY
3.3.1. UNTAPPED EMERGING MARKETS
3.4. MARKET CHALLENGES
3.4.1. SHORTAGE OF VET PRACTITIONERS ESPECIALLY IN DEVELOPING MARKETS
3.4.2. LACK OF ANIMAL HEALTHCARE AWARENESS IN EMERGING MARKETS
4. MARKET SEGMENTATION
4.1. GLOBAL VETERINARY IMAGING MARKET BY PRODUCT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL INSTRUMENTS MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL REAGENTS MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SOFTWARE MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL VETERINARY IMAGING MARKET BY ANIMAL TYPE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL SMALL COMPANION ANIMALS MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL LARGE ANIMALS MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL OTHER ANIMALS MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL VETERINARY IMAGING MARKET BY THERAPEUTIC AREA
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL ORTHOPEDICS AND TRAUMATOLOGY MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL ONCOLOGY MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL CARDIOLOGY MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. GLOBAL NEUROLOGY MARKET
4.3.5.4.1. APPLICATION
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.3.5.5. GLOBAL OTHER THERAPEUTIC AREAS MARKET
4.3.5.5.1. APPLICATION
4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.5.5. KEY CONCLUSIONS
4.4. GLOBAL VETERINARY IMAGING MARKET BY END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. GLOBAL CLINICS MARKET
4.4.5.1.1. APPLICATION
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL HOSPITALS AND INSTITUTIONS MARKET
4.4.5.2.1. APPLICATION
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.4.5.2.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL VETERINARY IMAGING MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. KEY COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. KEY COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. KEY COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. KEY COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. GE HEALTHCARE (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. AGFA-GEVAERT (BELGIUM)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. HALLMARQ VETERINARY IMAGING LTD. (U.K.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. DIAGNOSTIC IMAGING SYSTEMS, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. FUJIFILM HOLDINGS CORPORATION (JAPAN)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. ESAOTE SPA (ITALY)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. VCA INC. (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. EPICA MEDICAL INNOVATIONS (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. EXCELSIOR UNION LIMITED (CHINA)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. IDEXX LABORATORIES, INC. (U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. ONEX CORPORATION (CHINA)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. SEDECAL USA, INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. BCF TECHNOLOGY, LTD. (U.K.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. MINXRAY INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. HITACHI, LTD.(JAPAN)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL VETERINARY IMAGING MARKET BY PRODUCT 2014-2023 ($ MILLION)
GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL REAGENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY ANIMAL TYPE 2014-2023 ($ MILLION)
GLOBAL SMALL COMPANION ANIMALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL LARGE ANIMALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL OTHER ANIMALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY THERAPEUTIC AREA 2014-2023 ($ MILLION)
GLOBAL ORTHOPEDICS AND TRAUMATOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL ONCOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL CARDIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEUROLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL OTHER THERAPEUTIC AREAS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY END USER 2014-2023 ($ MILLION)
GLOBAL CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL HOSPITALS & ACADEMIC INSTITUTIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
EUROPE VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY PRODUCT 2014-2023 ($ MILLION)
GLOBAL INSTRUMENTS MARKET 2014-2023 ($ MILLION)
GLOBAL REAGENTS MARKET 2014-2023 ($ MILLION)
GLOBAL SOFTWARE MARKET 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY ANIMAL TYPE 2014-2023 ($ MILLION)
GLOBAL SMALL COMPANION ANIMALS MARKET 2014-2023 ($ MILLION)
GLOBAL LARGE ANIMALS MARKET 2014-2023 ($ MILLION)
GLOBAL OTHER ANIMALS MARKET 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY THERAPEUTIC AREA 2014-2023 ($ MILLION)
GLOBAL ORTHOPEDICS AND TRAUMATOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL ONCOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL NEUROLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL OTHER THERAPEUTIC AREAS MARKET 2014-2023 ($ MILLION)
GLOBAL VETERINARY IMAGING MARKET BY END USER 2014-2023 ($ MILLION)
GLOBAL CLINICS MARKET 2014-2023 ($ MILLION)
GLOBAL HOSPITALS & ACADEMIC INSTITUTIONS MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
CANADA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
FRANCE VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
GERMANY VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
SPAIN VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
ROE VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
INDIA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
CHINA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
JAPAN VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
AUSTRALIA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
ROAPAC VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
LATIN AMERICA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)
MENA VETERINARY IMAGING MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report